Furthermore, an additional marker can be intergration in the CellSearch System such as for example HER2 [41] which allows differentiation of CTC subpopulations of breast cancer (e.g. EpCAM+/HER2− vs. EpCAM+/HER2+). Here, EPCAM is linked to breast carcinoma.